$AFCG

TANNENBAUM LEONARD M purchased $82K of AFCG

TANNENBAUM LEONARD M purchased 25,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.28 on 2026-08-21.

Original reporting
SEC EDGAR · TANNENBAUM LEONARD M
Published Aug 24, 2026, 8:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AFCG
Neutral
medium confidence
Mentioned
$AFCG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFCGNeutralLow
01

Why it matters

The transaction adds to the insider ownership profile but is unlikely to affect stock price materially.

02

Market read

Primary insider purchase filing; modest size limits trading relevance.

03

What to watch

Potential upcoming corporate actions or financing that prompted the purchase.

Relevance 4/10Novelty 7/10Timing: post‑market filing

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$AFCGNeutralMedium confidence
Context

Director Leonard Tannenbaum purchased 25,000 shares of Advanced Flower Capital for $82,000, increasing his stake to over 6.6 million shares.

Expected impact

Limited short-term impact; potential slight upside if market perceives insider confidence.

Evidence & confidence

Purchase amount is under $100k and represents a routine 10b5‑1‑free transaction; unlikely to move price materially.

Market effects

Minimal effect on cannabis sector; insider activity is routine.

No regional impact.

Not globally relevant.

Counterpoint

The buy could be a window‑dressing move rather than genuine confidence.

Key entities

  • Advanced Flower Capital Inc.

    US‑listed cannabis investment company.

  • Leonard Tannenbaum

    Director and 10% owner of AFCG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFCGMed

Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript

Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.

$AFCGMed

Advanced Flower Capital Inc. (AFCG): Results of Operations and Financial Condition

Advanced Flower Capital Inc. (AFCG) filed an SEC Form 8-K — Results of Operations and Financial Condition. AFC Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net investment income (“NII”) of $3.5 million, or $0.15 per weighted average share WEST PALM BEACH, FL, August 13, 2026 – Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC,” or the “Company”) tod

$AFCGMed

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) said it committed $7.0 million to a $25.0 million senior secured credit facility, including a term loan and delayed draw term loan. An AFC affiliate will add $5.0 million, for $12.0 million total. Proceeds will refinance existing capital and fund acquisitions for an outpatient behavioral health platform. The facility has a four-year term.